Global Behcet's Disease Treatment Market
Global Behcet's Disease Treatment Market

Behcet's Disease Treatment Comprehensive Study by Type (Anti-inflammatory Medications (Ibuprofen), Topical Ointments (Corticosteroid), Immunosuppressive Medications), Route of Administration (Oral, Intravenous, Intramuscular, Topical, Others), End-users (Hospitals, Clinics, Ambulatory Surgical Centres, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) Players and Region - Global Market Outlook to 2025

Behcet's Disease Treatment Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Jun 2020 Edition 215 Pages 213 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Behcet's Disease Treatment Market Scope
Bechet's disease or disorder is a rare disorder that causes blood vessel inflammation throughout the body. It has various symptoms such as vascular problems, oral sores, genital and skin sores, eye inflammation, arthritis, and inflammation of the gut, brain, and spinal cord that varies from person to person. It is most commonly seen in Turkey but occurs in other countries throughout the world. According to the American BehÁetís Disease Association, the prevalence of Behcetís disease in Turkey is as high as 400 cases per 100,000 people. There is currently no cure for Behcet's disease, but the number of treatments can relieve symptoms and reduce the risk of serious complications.

The market study is being classified by Type (Anti-inflammatory Medications (Ibuprofen), Topical Ointments (Corticosteroid) and Immunosuppressive Medications) and major geographies with country level break-up.

The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Behcet's Disease Treatment market throughout the predicted period.

Novartis AG (Switzerland), AbbVie Inc (United States), Panacea Biotec Ltd (Indis, Abbott Laboratories (United States), F. Hoffmann-La Roche AG (Switzerland), Cell Medica Limited (United Kingdom), Celgene Corporation (United States) and Coherus BioSciences Inc (United States) are some of the key players profiled in the study.

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Behcet's Disease Treatment market by Type, Application and Region.

On the basis of geography, the market of Behcet's Disease Treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

In May 2020, AbbVie, a research-based global biopharmaceutical company, announced that it has completed its acquisition of Allergan plc following receipt of regulatory approval from all government authorities required by the transaction agreement and approval by the Irish High Court.


Market Trend
  • Increased Government Funding for Research and Development Activities
  • Rise in the Healthcare Expenditure in Emerging Countries

Market Drivers
  • Increased Prevalence of Behcet's Disease
  • High Demand for Complete Cure of Behcet's Disease
  • Increased Number of Diagnostic Centres and Hospitals

Opportunities
  • Growing Healthcare Industry Worldwide
  • Developments of New Markets
  • Increasing Awareness among People about Preventive Healthcare

Restraints
  • No Complete Cure of Behcet's Disease Available in the Market
  • Side Effects of Medications Associated with Treatment

Challenges
  • Stringent Government Rules and regulations


Key Target Audience
Behcet's Disease Treatment Providers, Raw Material Suppliers, Distributors, Emerging Companies and End-users

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Anti-inflammatory Medications (Ibuprofen)
  • Topical Ointments (Corticosteroid)
  • Immunosuppressive Medications
By Route of Administration
  • Oral
  • Intravenous
  • Intramuscular
  • Topical
  • Others

By End-users
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centres
  • Others

By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Prevalence of Behcet's Disease
      • 3.2.2. High Demand for Complete Cure of Behcet's Disease
      • 3.2.3. Increased Number of Diagnostic Centres and Hospitals
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Rules and regulations
    • 3.4. Market Trends
      • 3.4.1. Increased Government Funding for Research and Development Activities
      • 3.4.2. Rise in the Healthcare Expenditure in Emerging Countries
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Behcet's Disease Treatment, by Type, Route of Administration, End-users, Distribution Channel and Region (value) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Behcet's Disease Treatment (Value)
      • 5.2.1. Global Behcet's Disease Treatment by: Type (Value)
        • 5.2.1.1. Anti-inflammatory Medications (Ibuprofen)
        • 5.2.1.2. Topical Ointments (Corticosteroid)
        • 5.2.1.3. Immunosuppressive Medications
      • 5.2.2. Global Behcet's Disease Treatment by: Route of Administration (Value)
        • 5.2.2.1. Oral
        • 5.2.2.2. Intravenous
        • 5.2.2.3. Intramuscular
        • 5.2.2.4. Topical
        • 5.2.2.5. Others
      • 5.2.3. Global Behcet's Disease Treatment by: End-users (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Clinics
        • 5.2.3.3. Ambulatory Surgical Centres
        • 5.2.3.4. Others
      • 5.2.4. Global Behcet's Disease Treatment by: Distribution Channel (Value)
        • 5.2.4.1. Hospital Pharmacies
        • 5.2.4.2. Retail Pharmacies
        • 5.2.4.3. Online Pharmacies
        • 5.2.4.4. Others
      • 5.2.5. Global Behcet's Disease Treatment Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Behcet's Disease Treatment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Novartis AG (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. AbbVie Inc (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Panacea Biotec Ltd (Indis
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Abbott Laboratories (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. F. Hoffmann-La Roche AG (Switzerland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Cell Medica Limited (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Celgene Corporation (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Coherus BioSciences Inc (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Behcet's Disease Treatment Sale, by Type, Route of Administration, End-users, Distribution Channel and Region (value) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Behcet's Disease Treatment (Value)
      • 7.2.1. Global Behcet's Disease Treatment by: Type (Value)
        • 7.2.1.1. Anti-inflammatory Medications (Ibuprofen)
        • 7.2.1.2. Topical Ointments (Corticosteroid)
        • 7.2.1.3. Immunosuppressive Medications
      • 7.2.2. Global Behcet's Disease Treatment by: Route of Administration (Value)
        • 7.2.2.1. Oral
        • 7.2.2.2. Intravenous
        • 7.2.2.3. Intramuscular
        • 7.2.2.4. Topical
        • 7.2.2.5. Others
      • 7.2.3. Global Behcet's Disease Treatment by: End-users (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Clinics
        • 7.2.3.3. Ambulatory Surgical Centres
        • 7.2.3.4. Others
      • 7.2.4. Global Behcet's Disease Treatment by: Distribution Channel (Value)
        • 7.2.4.1. Hospital Pharmacies
        • 7.2.4.2. Retail Pharmacies
        • 7.2.4.3. Online Pharmacies
        • 7.2.4.4. Others
      • 7.2.5. Global Behcet's Disease Treatment Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Behcet's Disease Treatment: by Type(USD Million)
  • Table 2. Behcet's Disease Treatment Anti-inflammatory Medications (Ibuprofen) , by Region USD Million (2014-2019)
  • Table 3. Behcet's Disease Treatment Topical Ointments (Corticosteroid) , by Region USD Million (2014-2019)
  • Table 4. Behcet's Disease Treatment Immunosuppressive Medications , by Region USD Million (2014-2019)
  • Table 5. Behcet's Disease Treatment: by Route of Administration(USD Million)
  • Table 6. Behcet's Disease Treatment Oral , by Region USD Million (2014-2019)
  • Table 7. Behcet's Disease Treatment Intravenous , by Region USD Million (2014-2019)
  • Table 8. Behcet's Disease Treatment Intramuscular , by Region USD Million (2014-2019)
  • Table 9. Behcet's Disease Treatment Topical , by Region USD Million (2014-2019)
  • Table 10. Behcet's Disease Treatment Others , by Region USD Million (2014-2019)
  • Table 11. Behcet's Disease Treatment: by End-users(USD Million)
  • Table 12. Behcet's Disease Treatment Hospitals , by Region USD Million (2014-2019)
  • Table 13. Behcet's Disease Treatment Clinics , by Region USD Million (2014-2019)
  • Table 14. Behcet's Disease Treatment Ambulatory Surgical Centres , by Region USD Million (2014-2019)
  • Table 15. Behcet's Disease Treatment Others , by Region USD Million (2014-2019)
  • Table 16. Behcet's Disease Treatment: by Distribution Channel(USD Million)
  • Table 17. Behcet's Disease Treatment Hospital Pharmacies , by Region USD Million (2014-2019)
  • Table 18. Behcet's Disease Treatment Retail Pharmacies , by Region USD Million (2014-2019)
  • Table 19. Behcet's Disease Treatment Online Pharmacies , by Region USD Million (2014-2019)
  • Table 20. Behcet's Disease Treatment Others , by Region USD Million (2014-2019)
  • Table 21. South America Behcet's Disease Treatment, by Country USD Million (2014-2019)
  • Table 22. South America Behcet's Disease Treatment, by Type USD Million (2014-2019)
  • Table 23. South America Behcet's Disease Treatment, by Route of Administration USD Million (2014-2019)
  • Table 24. South America Behcet's Disease Treatment, by End-users USD Million (2014-2019)
  • Table 25. South America Behcet's Disease Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 26. Brazil Behcet's Disease Treatment, by Type USD Million (2014-2019)
  • Table 27. Brazil Behcet's Disease Treatment, by Route of Administration USD Million (2014-2019)
  • Table 28. Brazil Behcet's Disease Treatment, by End-users USD Million (2014-2019)
  • Table 29. Brazil Behcet's Disease Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 30. Argentina Behcet's Disease Treatment, by Type USD Million (2014-2019)
  • Table 31. Argentina Behcet's Disease Treatment, by Route of Administration USD Million (2014-2019)
  • Table 32. Argentina Behcet's Disease Treatment, by End-users USD Million (2014-2019)
  • Table 33. Argentina Behcet's Disease Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 34. Rest of South America Behcet's Disease Treatment, by Type USD Million (2014-2019)
  • Table 35. Rest of South America Behcet's Disease Treatment, by Route of Administration USD Million (2014-2019)
  • Table 36. Rest of South America Behcet's Disease Treatment, by End-users USD Million (2014-2019)
  • Table 37. Rest of South America Behcet's Disease Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 38. Asia Pacific Behcet's Disease Treatment, by Country USD Million (2014-2019)
  • Table 39. Asia Pacific Behcet's Disease Treatment, by Type USD Million (2014-2019)
  • Table 40. Asia Pacific Behcet's Disease Treatment, by Route of Administration USD Million (2014-2019)
  • Table 41. Asia Pacific Behcet's Disease Treatment, by End-users USD Million (2014-2019)
  • Table 42. Asia Pacific Behcet's Disease Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 43. China Behcet's Disease Treatment, by Type USD Million (2014-2019)
  • Table 44. China Behcet's Disease Treatment, by Route of Administration USD Million (2014-2019)
  • Table 45. China Behcet's Disease Treatment, by End-users USD Million (2014-2019)
  • Table 46. China Behcet's Disease Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 47. Japan Behcet's Disease Treatment, by Type USD Million (2014-2019)
  • Table 48. Japan Behcet's Disease Treatment, by Route of Administration USD Million (2014-2019)
  • Table 49. Japan Behcet's Disease Treatment, by End-users USD Million (2014-2019)
  • Table 50. Japan Behcet's Disease Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 51. India Behcet's Disease Treatment, by Type USD Million (2014-2019)
  • Table 52. India Behcet's Disease Treatment, by Route of Administration USD Million (2014-2019)
  • Table 53. India Behcet's Disease Treatment, by End-users USD Million (2014-2019)
  • Table 54. India Behcet's Disease Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 55. South Korea Behcet's Disease Treatment, by Type USD Million (2014-2019)
  • Table 56. South Korea Behcet's Disease Treatment, by Route of Administration USD Million (2014-2019)
  • Table 57. South Korea Behcet's Disease Treatment, by End-users USD Million (2014-2019)
  • Table 58. South Korea Behcet's Disease Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 59. Taiwan Behcet's Disease Treatment, by Type USD Million (2014-2019)
  • Table 60. Taiwan Behcet's Disease Treatment, by Route of Administration USD Million (2014-2019)
  • Table 61. Taiwan Behcet's Disease Treatment, by End-users USD Million (2014-2019)
  • Table 62. Taiwan Behcet's Disease Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 63. Australia Behcet's Disease Treatment, by Type USD Million (2014-2019)
  • Table 64. Australia Behcet's Disease Treatment, by Route of Administration USD Million (2014-2019)
  • Table 65. Australia Behcet's Disease Treatment, by End-users USD Million (2014-2019)
  • Table 66. Australia Behcet's Disease Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 67. Rest of Asia-Pacific Behcet's Disease Treatment, by Type USD Million (2014-2019)
  • Table 68. Rest of Asia-Pacific Behcet's Disease Treatment, by Route of Administration USD Million (2014-2019)
  • Table 69. Rest of Asia-Pacific Behcet's Disease Treatment, by End-users USD Million (2014-2019)
  • Table 70. Rest of Asia-Pacific Behcet's Disease Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 71. Europe Behcet's Disease Treatment, by Country USD Million (2014-2019)
  • Table 72. Europe Behcet's Disease Treatment, by Type USD Million (2014-2019)
  • Table 73. Europe Behcet's Disease Treatment, by Route of Administration USD Million (2014-2019)
  • Table 74. Europe Behcet's Disease Treatment, by End-users USD Million (2014-2019)
  • Table 75. Europe Behcet's Disease Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 76. Germany Behcet's Disease Treatment, by Type USD Million (2014-2019)
  • Table 77. Germany Behcet's Disease Treatment, by Route of Administration USD Million (2014-2019)
  • Table 78. Germany Behcet's Disease Treatment, by End-users USD Million (2014-2019)
  • Table 79. Germany Behcet's Disease Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 80. France Behcet's Disease Treatment, by Type USD Million (2014-2019)
  • Table 81. France Behcet's Disease Treatment, by Route of Administration USD Million (2014-2019)
  • Table 82. France Behcet's Disease Treatment, by End-users USD Million (2014-2019)
  • Table 83. France Behcet's Disease Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 84. Italy Behcet's Disease Treatment, by Type USD Million (2014-2019)
  • Table 85. Italy Behcet's Disease Treatment, by Route of Administration USD Million (2014-2019)
  • Table 86. Italy Behcet's Disease Treatment, by End-users USD Million (2014-2019)
  • Table 87. Italy Behcet's Disease Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 88. United Kingdom Behcet's Disease Treatment, by Type USD Million (2014-2019)
  • Table 89. United Kingdom Behcet's Disease Treatment, by Route of Administration USD Million (2014-2019)
  • Table 90. United Kingdom Behcet's Disease Treatment, by End-users USD Million (2014-2019)
  • Table 91. United Kingdom Behcet's Disease Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 92. Netherlands Behcet's Disease Treatment, by Type USD Million (2014-2019)
  • Table 93. Netherlands Behcet's Disease Treatment, by Route of Administration USD Million (2014-2019)
  • Table 94. Netherlands Behcet's Disease Treatment, by End-users USD Million (2014-2019)
  • Table 95. Netherlands Behcet's Disease Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 96. Rest of Europe Behcet's Disease Treatment, by Type USD Million (2014-2019)
  • Table 97. Rest of Europe Behcet's Disease Treatment, by Route of Administration USD Million (2014-2019)
  • Table 98. Rest of Europe Behcet's Disease Treatment, by End-users USD Million (2014-2019)
  • Table 99. Rest of Europe Behcet's Disease Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 100. MEA Behcet's Disease Treatment, by Country USD Million (2014-2019)
  • Table 101. MEA Behcet's Disease Treatment, by Type USD Million (2014-2019)
  • Table 102. MEA Behcet's Disease Treatment, by Route of Administration USD Million (2014-2019)
  • Table 103. MEA Behcet's Disease Treatment, by End-users USD Million (2014-2019)
  • Table 104. MEA Behcet's Disease Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 105. Middle East Behcet's Disease Treatment, by Type USD Million (2014-2019)
  • Table 106. Middle East Behcet's Disease Treatment, by Route of Administration USD Million (2014-2019)
  • Table 107. Middle East Behcet's Disease Treatment, by End-users USD Million (2014-2019)
  • Table 108. Middle East Behcet's Disease Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 109. Africa Behcet's Disease Treatment, by Type USD Million (2014-2019)
  • Table 110. Africa Behcet's Disease Treatment, by Route of Administration USD Million (2014-2019)
  • Table 111. Africa Behcet's Disease Treatment, by End-users USD Million (2014-2019)
  • Table 112. Africa Behcet's Disease Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 113. North America Behcet's Disease Treatment, by Country USD Million (2014-2019)
  • Table 114. North America Behcet's Disease Treatment, by Type USD Million (2014-2019)
  • Table 115. North America Behcet's Disease Treatment, by Route of Administration USD Million (2014-2019)
  • Table 116. North America Behcet's Disease Treatment, by End-users USD Million (2014-2019)
  • Table 117. North America Behcet's Disease Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 118. United States Behcet's Disease Treatment, by Type USD Million (2014-2019)
  • Table 119. United States Behcet's Disease Treatment, by Route of Administration USD Million (2014-2019)
  • Table 120. United States Behcet's Disease Treatment, by End-users USD Million (2014-2019)
  • Table 121. United States Behcet's Disease Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 122. Canada Behcet's Disease Treatment, by Type USD Million (2014-2019)
  • Table 123. Canada Behcet's Disease Treatment, by Route of Administration USD Million (2014-2019)
  • Table 124. Canada Behcet's Disease Treatment, by End-users USD Million (2014-2019)
  • Table 125. Canada Behcet's Disease Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 126. Mexico Behcet's Disease Treatment, by Type USD Million (2014-2019)
  • Table 127. Mexico Behcet's Disease Treatment, by Route of Administration USD Million (2014-2019)
  • Table 128. Mexico Behcet's Disease Treatment, by End-users USD Million (2014-2019)
  • Table 129. Mexico Behcet's Disease Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Behcet's Disease Treatment: by Type(USD Million)
  • Table 139. Behcet's Disease Treatment Anti-inflammatory Medications (Ibuprofen) , by Region USD Million (2020-2025)
  • Table 140. Behcet's Disease Treatment Topical Ointments (Corticosteroid) , by Region USD Million (2020-2025)
  • Table 141. Behcet's Disease Treatment Immunosuppressive Medications , by Region USD Million (2020-2025)
  • Table 142. Behcet's Disease Treatment: by Route of Administration(USD Million)
  • Table 143. Behcet's Disease Treatment Oral , by Region USD Million (2020-2025)
  • Table 144. Behcet's Disease Treatment Intravenous , by Region USD Million (2020-2025)
  • Table 145. Behcet's Disease Treatment Intramuscular , by Region USD Million (2020-2025)
  • Table 146. Behcet's Disease Treatment Topical , by Region USD Million (2020-2025)
  • Table 147. Behcet's Disease Treatment Others , by Region USD Million (2020-2025)
  • Table 148. Behcet's Disease Treatment: by End-users(USD Million)
  • Table 149. Behcet's Disease Treatment Hospitals , by Region USD Million (2020-2025)
  • Table 150. Behcet's Disease Treatment Clinics , by Region USD Million (2020-2025)
  • Table 151. Behcet's Disease Treatment Ambulatory Surgical Centres , by Region USD Million (2020-2025)
  • Table 152. Behcet's Disease Treatment Others , by Region USD Million (2020-2025)
  • Table 153. Behcet's Disease Treatment: by Distribution Channel(USD Million)
  • Table 154. Behcet's Disease Treatment Hospital Pharmacies , by Region USD Million (2020-2025)
  • Table 155. Behcet's Disease Treatment Retail Pharmacies , by Region USD Million (2020-2025)
  • Table 156. Behcet's Disease Treatment Online Pharmacies , by Region USD Million (2020-2025)
  • Table 157. Behcet's Disease Treatment Others , by Region USD Million (2020-2025)
  • Table 158. South America Behcet's Disease Treatment, by Country USD Million (2020-2025)
  • Table 159. South America Behcet's Disease Treatment, by Type USD Million (2020-2025)
  • Table 160. South America Behcet's Disease Treatment, by Route of Administration USD Million (2020-2025)
  • Table 161. South America Behcet's Disease Treatment, by End-users USD Million (2020-2025)
  • Table 162. South America Behcet's Disease Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 163. Brazil Behcet's Disease Treatment, by Type USD Million (2020-2025)
  • Table 164. Brazil Behcet's Disease Treatment, by Route of Administration USD Million (2020-2025)
  • Table 165. Brazil Behcet's Disease Treatment, by End-users USD Million (2020-2025)
  • Table 166. Brazil Behcet's Disease Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 167. Argentina Behcet's Disease Treatment, by Type USD Million (2020-2025)
  • Table 168. Argentina Behcet's Disease Treatment, by Route of Administration USD Million (2020-2025)
  • Table 169. Argentina Behcet's Disease Treatment, by End-users USD Million (2020-2025)
  • Table 170. Argentina Behcet's Disease Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 171. Rest of South America Behcet's Disease Treatment, by Type USD Million (2020-2025)
  • Table 172. Rest of South America Behcet's Disease Treatment, by Route of Administration USD Million (2020-2025)
  • Table 173. Rest of South America Behcet's Disease Treatment, by End-users USD Million (2020-2025)
  • Table 174. Rest of South America Behcet's Disease Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 175. Asia Pacific Behcet's Disease Treatment, by Country USD Million (2020-2025)
  • Table 176. Asia Pacific Behcet's Disease Treatment, by Type USD Million (2020-2025)
  • Table 177. Asia Pacific Behcet's Disease Treatment, by Route of Administration USD Million (2020-2025)
  • Table 178. Asia Pacific Behcet's Disease Treatment, by End-users USD Million (2020-2025)
  • Table 179. Asia Pacific Behcet's Disease Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 180. China Behcet's Disease Treatment, by Type USD Million (2020-2025)
  • Table 181. China Behcet's Disease Treatment, by Route of Administration USD Million (2020-2025)
  • Table 182. China Behcet's Disease Treatment, by End-users USD Million (2020-2025)
  • Table 183. China Behcet's Disease Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 184. Japan Behcet's Disease Treatment, by Type USD Million (2020-2025)
  • Table 185. Japan Behcet's Disease Treatment, by Route of Administration USD Million (2020-2025)
  • Table 186. Japan Behcet's Disease Treatment, by End-users USD Million (2020-2025)
  • Table 187. Japan Behcet's Disease Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 188. India Behcet's Disease Treatment, by Type USD Million (2020-2025)
  • Table 189. India Behcet's Disease Treatment, by Route of Administration USD Million (2020-2025)
  • Table 190. India Behcet's Disease Treatment, by End-users USD Million (2020-2025)
  • Table 191. India Behcet's Disease Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 192. South Korea Behcet's Disease Treatment, by Type USD Million (2020-2025)
  • Table 193. South Korea Behcet's Disease Treatment, by Route of Administration USD Million (2020-2025)
  • Table 194. South Korea Behcet's Disease Treatment, by End-users USD Million (2020-2025)
  • Table 195. South Korea Behcet's Disease Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 196. Taiwan Behcet's Disease Treatment, by Type USD Million (2020-2025)
  • Table 197. Taiwan Behcet's Disease Treatment, by Route of Administration USD Million (2020-2025)
  • Table 198. Taiwan Behcet's Disease Treatment, by End-users USD Million (2020-2025)
  • Table 199. Taiwan Behcet's Disease Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 200. Australia Behcet's Disease Treatment, by Type USD Million (2020-2025)
  • Table 201. Australia Behcet's Disease Treatment, by Route of Administration USD Million (2020-2025)
  • Table 202. Australia Behcet's Disease Treatment, by End-users USD Million (2020-2025)
  • Table 203. Australia Behcet's Disease Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 204. Rest of Asia-Pacific Behcet's Disease Treatment, by Type USD Million (2020-2025)
  • Table 205. Rest of Asia-Pacific Behcet's Disease Treatment, by Route of Administration USD Million (2020-2025)
  • Table 206. Rest of Asia-Pacific Behcet's Disease Treatment, by End-users USD Million (2020-2025)
  • Table 207. Rest of Asia-Pacific Behcet's Disease Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 208. Europe Behcet's Disease Treatment, by Country USD Million (2020-2025)
  • Table 209. Europe Behcet's Disease Treatment, by Type USD Million (2020-2025)
  • Table 210. Europe Behcet's Disease Treatment, by Route of Administration USD Million (2020-2025)
  • Table 211. Europe Behcet's Disease Treatment, by End-users USD Million (2020-2025)
  • Table 212. Europe Behcet's Disease Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 213. Germany Behcet's Disease Treatment, by Type USD Million (2020-2025)
  • Table 214. Germany Behcet's Disease Treatment, by Route of Administration USD Million (2020-2025)
  • Table 215. Germany Behcet's Disease Treatment, by End-users USD Million (2020-2025)
  • Table 216. Germany Behcet's Disease Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 217. France Behcet's Disease Treatment, by Type USD Million (2020-2025)
  • Table 218. France Behcet's Disease Treatment, by Route of Administration USD Million (2020-2025)
  • Table 219. France Behcet's Disease Treatment, by End-users USD Million (2020-2025)
  • Table 220. France Behcet's Disease Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 221. Italy Behcet's Disease Treatment, by Type USD Million (2020-2025)
  • Table 222. Italy Behcet's Disease Treatment, by Route of Administration USD Million (2020-2025)
  • Table 223. Italy Behcet's Disease Treatment, by End-users USD Million (2020-2025)
  • Table 224. Italy Behcet's Disease Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 225. United Kingdom Behcet's Disease Treatment, by Type USD Million (2020-2025)
  • Table 226. United Kingdom Behcet's Disease Treatment, by Route of Administration USD Million (2020-2025)
  • Table 227. United Kingdom Behcet's Disease Treatment, by End-users USD Million (2020-2025)
  • Table 228. United Kingdom Behcet's Disease Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 229. Netherlands Behcet's Disease Treatment, by Type USD Million (2020-2025)
  • Table 230. Netherlands Behcet's Disease Treatment, by Route of Administration USD Million (2020-2025)
  • Table 231. Netherlands Behcet's Disease Treatment, by End-users USD Million (2020-2025)
  • Table 232. Netherlands Behcet's Disease Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 233. Rest of Europe Behcet's Disease Treatment, by Type USD Million (2020-2025)
  • Table 234. Rest of Europe Behcet's Disease Treatment, by Route of Administration USD Million (2020-2025)
  • Table 235. Rest of Europe Behcet's Disease Treatment, by End-users USD Million (2020-2025)
  • Table 236. Rest of Europe Behcet's Disease Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 237. MEA Behcet's Disease Treatment, by Country USD Million (2020-2025)
  • Table 238. MEA Behcet's Disease Treatment, by Type USD Million (2020-2025)
  • Table 239. MEA Behcet's Disease Treatment, by Route of Administration USD Million (2020-2025)
  • Table 240. MEA Behcet's Disease Treatment, by End-users USD Million (2020-2025)
  • Table 241. MEA Behcet's Disease Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 242. Middle East Behcet's Disease Treatment, by Type USD Million (2020-2025)
  • Table 243. Middle East Behcet's Disease Treatment, by Route of Administration USD Million (2020-2025)
  • Table 244. Middle East Behcet's Disease Treatment, by End-users USD Million (2020-2025)
  • Table 245. Middle East Behcet's Disease Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 246. Africa Behcet's Disease Treatment, by Type USD Million (2020-2025)
  • Table 247. Africa Behcet's Disease Treatment, by Route of Administration USD Million (2020-2025)
  • Table 248. Africa Behcet's Disease Treatment, by End-users USD Million (2020-2025)
  • Table 249. Africa Behcet's Disease Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 250. North America Behcet's Disease Treatment, by Country USD Million (2020-2025)
  • Table 251. North America Behcet's Disease Treatment, by Type USD Million (2020-2025)
  • Table 252. North America Behcet's Disease Treatment, by Route of Administration USD Million (2020-2025)
  • Table 253. North America Behcet's Disease Treatment, by End-users USD Million (2020-2025)
  • Table 254. North America Behcet's Disease Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 255. United States Behcet's Disease Treatment, by Type USD Million (2020-2025)
  • Table 256. United States Behcet's Disease Treatment, by Route of Administration USD Million (2020-2025)
  • Table 257. United States Behcet's Disease Treatment, by End-users USD Million (2020-2025)
  • Table 258. United States Behcet's Disease Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 259. Canada Behcet's Disease Treatment, by Type USD Million (2020-2025)
  • Table 260. Canada Behcet's Disease Treatment, by Route of Administration USD Million (2020-2025)
  • Table 261. Canada Behcet's Disease Treatment, by End-users USD Million (2020-2025)
  • Table 262. Canada Behcet's Disease Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 263. Mexico Behcet's Disease Treatment, by Type USD Million (2020-2025)
  • Table 264. Mexico Behcet's Disease Treatment, by Route of Administration USD Million (2020-2025)
  • Table 265. Mexico Behcet's Disease Treatment, by End-users USD Million (2020-2025)
  • Table 266. Mexico Behcet's Disease Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 267. Research Programs/Design for This Report
  • Table 268. Key Data Information from Secondary Sources
  • Table 269. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Behcet's Disease Treatment: by Type USD Million (2014-2019)
  • Figure 5. Global Behcet's Disease Treatment: by Route of Administration USD Million (2014-2019)
  • Figure 6. Global Behcet's Disease Treatment: by End-users USD Million (2014-2019)
  • Figure 7. Global Behcet's Disease Treatment: by Distribution Channel USD Million (2014-2019)
  • Figure 8. South America Behcet's Disease Treatment Share (%), by Country
  • Figure 9. Asia Pacific Behcet's Disease Treatment Share (%), by Country
  • Figure 10. Europe Behcet's Disease Treatment Share (%), by Country
  • Figure 11. MEA Behcet's Disease Treatment Share (%), by Country
  • Figure 12. North America Behcet's Disease Treatment Share (%), by Country
  • Figure 13. Global Behcet's Disease Treatment share by Players 2019 (%)
  • Figure 14. Global Behcet's Disease Treatment share by Players (Top 3) 2019(%)
  • Figure 15. Global Behcet's Disease Treatment share by Players (Top 5) 2019(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Novartis AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 18. Novartis AG (Switzerland) Revenue: by Geography 2019
  • Figure 19. AbbVie Inc (United States) Revenue, Net Income and Gross profit
  • Figure 20. AbbVie Inc (United States) Revenue: by Geography 2019
  • Figure 21. Panacea Biotec Ltd (Indis Revenue, Net Income and Gross profit
  • Figure 22. Panacea Biotec Ltd (Indis Revenue: by Geography 2019
  • Figure 23. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 24. Abbott Laboratories (United States) Revenue: by Geography 2019
  • Figure 25. F. Hoffmann-La Roche AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 26. F. Hoffmann-La Roche AG (Switzerland) Revenue: by Geography 2019
  • Figure 27. Cell Medica Limited (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 28. Cell Medica Limited (United Kingdom) Revenue: by Geography 2019
  • Figure 29. Celgene Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 30. Celgene Corporation (United States) Revenue: by Geography 2019
  • Figure 31. Coherus BioSciences Inc (United States) Revenue, Net Income and Gross profit
  • Figure 32. Coherus BioSciences Inc (United States) Revenue: by Geography 2019
  • Figure 33. Global Behcet's Disease Treatment: by Type USD Million (2020-2025)
  • Figure 34. Global Behcet's Disease Treatment: by Route of Administration USD Million (2020-2025)
  • Figure 35. Global Behcet's Disease Treatment: by End-users USD Million (2020-2025)
  • Figure 36. Global Behcet's Disease Treatment: by Distribution Channel USD Million (2020-2025)
  • Figure 37. South America Behcet's Disease Treatment Share (%), by Country
  • Figure 38. Asia Pacific Behcet's Disease Treatment Share (%), by Country
  • Figure 39. Europe Behcet's Disease Treatment Share (%), by Country
  • Figure 40. MEA Behcet's Disease Treatment Share (%), by Country
  • Figure 41. North America Behcet's Disease Treatment Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Novartis AG (Switzerland)
  • AbbVie Inc (United States)
  • Panacea Biotec Ltd (Indis
  • Abbott Laboratories (United States)
  • F. Hoffmann-La Roche AG (Switzerland)
  • Cell Medica Limited (United Kingdom)
  • Celgene Corporation (United States)
  • Coherus BioSciences Inc (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation